4 Recruiting Trials

Clinical Trials for Alzheimer's in Nebraska

4 clinical trials for Alzheimer's are currently recruiting participants at study sites in Nebraska. Study-related care is provided at no cost.

Showing 4 of 4 recruiting Alzheimer's trials in Nebraska

[18F]PI-2620 Phase 3 Histopathological Study
PHASE3 Phoenix, Arizona +4 sites NCT05641688
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2 Chandler, Arizona +4 sites NCT06159673
Recruiting

Alzheimer's clinical trials in Nebraska: common questions

How many Alzheimer's clinical trials are recruiting in Nebraska?
TrialFinder currently lists 4 recruiting Alzheimer's clinical trials with study sites in Nebraska. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Alzheimer's clinical trials located in Nebraska?
Sites for these Alzheimer's trials are spread across Nebraska. Open any trial to see its full list of participating locations and contact details.
Do I need insurance to join a Alzheimer's clinical trial in Nebraska?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Alzheimer's trials in Nebraska also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Alzheimer's clinical trial in Nebraska?
Each study sets its own criteria based on age, Alzheimer's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Alzheimer's trials near you in Nebraska.

Get Matched — Free
No insurance required

Alzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.

All Alzheimer's trials →